2 Jun 2017

Transparency notifications BlackRock, Inc.

Read More
2 Jun 2017

Transparency notification 

Read More
29 May 2017

Transparency notification 

Read More
23 May 2017

Transparency notification 

Read More
23 May 2017

Transparency notifications BlackRock, Inc.

Read More
21 May 2017

UCB and Amgen announce top-line phase 3 data from active-comparator study of Evenity™ (romosozumab) in postmenopausal women with osteoporosis

Read More
17 May 2017

Transparency notification 

Read More
27 Apr 2017

UCB's General Meeting of Shareholders

Read More
26 Apr 2017

UCB receives positive CHMP opinion for CIMZIA® (certolizumab pegol) dose dispenser cartridge for use with ava® electronic injection device

Read More
24 Apr 2017

UCB First Three Months Interim Report 2017: UCB with a good start into 2017

Read More
Subscribe to